drugset / Trial / NCT04202211

FMT for Remission of Active Ulcerative Colitis in Adults

NCT04202211 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The goal of this study is to establish the safety and effectiveness of lyophilized (LYO) fecal microbiota transplant (FMT) for treating ulcerative colitis (UC) in adults. The protocol is being re-designed to address relevant, current research questions in the context of FMT treatment for UC. Once a final protocol is approved, this webpage will be updated.

Timeline

Start
2022-03
Primary completion
2024-12
Completion
2028-12

Outcome

Outcome not reported

Stopped: “Protocol changed substantially enough to warrant a separate submission”

Drugs

EvaluationDrugModalityDoseRoute
Comparator FMT Unknown 1 unknown Oral
Comparator FMT Unknown 1 unknown Oral
Comparator FMT Unknown 10 unknown Oral
Comparator FMT Unknown 10 unknown Oral

Indications